Investor profile
UNC Health Ventures
Corporate venture fund of the UNC Health system, established in 2012 as Rex Health Ventures with about $10 million and a Triangle focus, and renamed UNC Health Ventures on 2026-08-18 with $125 million to invest over the next decade from reallocated capital reserves. Invests primarily at Series A and Series B across medtech, healthtech, and biotech, is geographically agnostic, and has backed 30 companies with 12 active as of the rebrand. Anita Watkins and John Perez are managing directors. Active Triangle holdings include 410 Medical, baebies, Phononic, and Pryon; Emergo Therapeutics is a prior investment.
Directory portfolio
Companies connected here
6
410 Medical
LifeFlow rapid fluid infusion devices
- A
Arrivo BioVentures
Clinical-stage drug developer with two candidates: forvisirvat (SP-624), a SIRT6 activator in Phase 2b/3 for major depressive disorder, and RABI-767 for predicted severe acute pancreatitis.
baebies
Newborn screening and pediatric diagnostics company building digital microfluidics platforms for near-patient testing.
Emergo Therapeutics
Biotech company developing immunomodulating therapies for cytokine-linked inflammatory conditions.
Phononic
Solid-state electronics for refrigeration without harmful gases
Pryon
AI enterprise knowledge management and assistant platform
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.